Dr. Greg Carter, MD, MSis a physiatrist and chief medical officer of St Luke’s Rehabilitation Institute in Spokane, WA. His clinical research has helped characterize relationships between pain, quality of life, and function in neuromuscular disorders (NMDs). He has investigated the potential role of cannabinoids in managing the symptoms and clinical course of amyotrophic lateral sclerosis (ALS) and was among the first investigators to report that. He has received the Distinguished Researcher Award from the American Association of Neuromuscular and Electrodiagnostic Medicine, the Best Research Paper Award from the American Academy of Physical Medicine and Rehabilitation, and the Excellence in Research Writing Award from the Association of Academic Physiatrists.